A Trial to Investigate the Efficacy and Safety of Ultra-Low Dose HRT for Treatment of Menopausal Symptoms.
Phase of Trial: Phase III
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Estradiol (Primary) ; Norethisterone (Primary)
- Indications Hot flashes; Menopausal syndrome
- Focus Registrational; Therapeutic Use
- Acronyms CHOICE
- 12 May 2009 Actual patient number (576) added as reported by ClinicalTrials.gov.
- 12 May 2009 Actual end date (May 2005) added as reported by ClinicalTrials.gov.
- 05 Nov 2005 New trial record.